Dhammika Navarathna

Dr. Dhammika Navarathna

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Journal of Emergency Nursing
Verified
Journal Article
Closed access
MAMonica Arenas
Monica Arenas
GBGracia M. Boseman
Gracia M. Boseman
JCJohn D. Coppin
John D. Coppin
JLJanell Lukey
Janell Lukey
CJChetan Jinadatha
Chetan Jinadatha
DNDhammika Navarathna
Dhammika Navarathna

1 May 2021 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
DNDhammika Navarathna
Dhammika Navarathna
SSShawn Sharp
Shawn Sharp
JLJanell Lukey
Janell Lukey
MAMonica Arenas
Monica Arenas
HVHorace Villas
Horace Villas
CJChetan Jinadatha
Chetan Jinadatha

31 October 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DNDhammika Navarathna
Dhammika Navarathna
Michail LionakisMichail Lionakis
Michail Lionakis
David RobertsDavid Roberts
David Roberts
Three isoforms of nitric oxide synthase (NOS) occur in mammals. High levels of NO produced by NOS2/iNOS can protect against bacterial and parasitic infections, but the role of NOS in fungal innate immunity is less clear. Compared to wild type mice, Nos3-/- mice showed significantly higher survival of candidemia caused by Candida albicans SC5314. NOS3/eNOS is expressed by endothelial cells in the kidney, and colonization of this organ was decreased during the sub-acute stage of disseminated candidiasis. Nos3-/- mice more rapidly eliminated Candida from the renal cortex and exhibited more balanced local inflammatory reactions, with similar macrophage but less neutrophil infiltration than in infected wild type. Levels of the serum cytokines IL-9, IL-12, IL-17 and chemokines GM-CSF, MIP1α, and MIP1β were significantly elevated, and IL-15 was significantly lower in infected Nos3-/- mice. Spleens of infected Nos3-/- mice had significantly more Th2 and Th9 but not other CD4+ T cells compared with wild type. Inflammatory genes associated with leukocyte chemotaxis, IL-1 signaling, TLR signaling and Th1 and Th2 cell differentiation pathways were significantly overexpressed in infected Nos3-/- kidneys, with Nos2 being the most strongly induced. Conversely, the general NOS inhibitor NG-nitro-L-arginine methyl ester increased virulence in the mouse candidemia model, suggesting that iNOS contributes to the protective mechanism in infected Nos3-/- mice. By moderating neutrophil infiltration, the absence of eNOS may reduce the collateral damage to kidney cortex, and Th-9 CD4+ cells may enhance clearance of the infection. These data suggest that selective eNOS inhibition could mitigate candidemia by a combination of systemic and local responses that promote a more effective host immune response.

20 April 2022 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
HCHosoon Choi
Hosoon Choi
MHMunok Hwang
Munok Hwang
DNDhammika Navarathna
Dhammika Navarathna
JXJing Xu
Jing Xu
JLJanell Lukey
Janell Lukey
CJChetan Jinadatha
Chetan Jinadatha

21 April 2022 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
HCHosoon Choi
Hosoon Choi
MHMunok Hwang
Munok Hwang
JLJanell Lukey
Janell Lukey
CJChetan Jinadatha
Chetan Jinadatha
DNDhammika Navarathna
Dhammika Navarathna

17 October 2023 in Microbiology Spectrum
Verified
Journal Article
Closed access
DNDhammika Navarathna
Dhammika Navarathna
JLJanell Lukey
Janell Lukey
JCJohn David Coppin
John David Coppin
CJChetan Jinadatha
Chetan Jinadatha
Vaginitis is usually diagnosed empirically, microscopically, via cultures, or by molecular testing for the detection of bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), or Trichomonas vaginalis (TV). The DNA probe–based technique detects BV by identifying Gardnerella vaginalis , VVC by identifying Candida spp., while real-time PCR-based detection methods identify BV by algorithmic analysis of the absence or presence of known vaginal flora. We examined 8,878 total orders placed for DNA probe–based identification (ID) and 10,464 total orders placed for molecular panel ID. We found that PCR-based BV test positivity reduced from 30% to 23% compared with the population tested with DNA probe–based testing. We also found that PCR-based testing VVC positivity increased from 6.3% and 11.6% when compared with DNA probe–based testing. Bayesian generalized linear analysis estimated a lower mean proportion of positive tests for BV in PCR-based molecular panels than DNA probe testing suggesting an under-call of BV. The same models estimated a higher mean proportion of positive tests for molecular vaginal panels than DNA probe testing suggesting an increased detection of candidal vaginitis. In addition, the mean (SD) age for patients with Candida albicans was 40.5 (40.0–41.1) years. Patients with Candida glabrata (now N. glabrata ) were 5.2–8.1 (mean 6.7) years older than patients with Candida albicans . Our retrospective data analysis found that BD Max MVP’s ability to discriminate between vaginal candidiasis versus other yeast will help to implement CDC (Centers for Disease Control and Prevention)-recommended treatment options. We also believe that providers’ inattention to non-albicans treatment could be an issue nationwide. IMPORTANCE: Using retrospective data from U.S. Food and Drug Administration-approved/cleared molecular vaginal panels, molecular methods were found to have higher detection for Candida vaginitis and lower detection for bacterial vaginitis when compared to probe-based methods. In addition, the differentiation of Candida and non- Candida yeast has not reached the physician community as we observed noncompliance in recommended therapy. Furthermore, the pros and cons of migrating to molecular testing from conventional microscopy for identifying bacterial vaginitis and fungal vaginitis have been examined and reported in this paper. Interestingly, the mean (SD) age for patients with Candida albicans was 40.5 (40.0–41.1) years. Patients with N. glabrata were 5.2–8.1 (mean 6.7) years older than patients with Candida albicans .